Dihexa research in Canada investigates the cognitive-enhancing and neuroplasticity-promoting properties of this synthetic heptapeptide. Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic peptidomimetic derived from Angiotensin IV that potentiates hepatocyte growth factor (HGF) activity at its receptor c-Met. Canadian neuroscience researchers study Dihexa for its reportedly potent effects on synaptic density, spatial memory, and cognitive function in animal models — some research suggests it is among the most potent nootropic compounds tested in rodent models.
HGF/MET Signalling Research
Hepatocyte growth factor (HGF) and its receptor c-Met are involved in neuronal survival, synaptic plasticity, and cognitive function. Dihexa acts as a positive allosteric potentiator of HGF/MET signalling rather than a direct agonist, amplifying existing HGF activity. Canadian neuroplasticity researchers study how this mechanism translates to changes in dendritic spine density, synaptogenesis, and hippocampal-dependent memory in animal models.
Cognitive Biology Research
Dihexa is studied for cognitive effects in models of neurodegeneration. Canadian researchers investigate Dihexa in Morris Water Maze and other spatial memory paradigms to understand how HGF/MET potentiation influences hippocampal circuit function. The compound’s ability to cross the blood-brain barrier following systemic administration makes it a useful research tool for studying CNS HGF signalling.
Sourcing Dihexa in Canada
Research-grade Dihexa is available in Canada from EhBuddy Peptides. Lab-tested for purity. For laboratory research use only.
Dihexa represents a fascinating frontier in Canadian nootropic peptide research, with unique HGF/MET pharmacology distinguishing it from classical cognitive peptides like semax and selank.
